235 related articles for article (PubMed ID: 20139172)
1. GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells.
Liao G; Nayak S; Regueiro JR; Berger SB; Detre C; Romero X; de Waal Malefyt R; Chatila TA; Herzog RW; Terhorst C
Int Immunol; 2010 Apr; 22(4):259-70. PubMed ID: 20139172
[TBL] [Abstract][Full Text] [Related]
2. Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer.
Cao O; Dobrzynski E; Wang L; Nayak S; Mingle B; Terhorst C; Herzog RW
Blood; 2007 Aug; 110(4):1132-40. PubMed ID: 17438084
[TBL] [Abstract][Full Text] [Related]
3. Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy.
Coe D; Begom S; Addey C; White M; Dyson J; Chai JG
Cancer Immunol Immunother; 2010 Sep; 59(9):1367-77. PubMed ID: 20480365
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.
Stroopinsky D; Avivi I; Rowe JM; Avigan D; Katz T
Eur J Immunol; 2009 Oct; 39(10):2703-15. PubMed ID: 19634189
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.
Ramirez-Montagut T; Chow A; Hirschhorn-Cymerman D; Terwey TH; Kochman AA; Lu S; Miles RC; Sakaguchi S; Houghton AN; van den Brink MR
J Immunol; 2006 Jun; 176(11):6434-42. PubMed ID: 16709800
[TBL] [Abstract][Full Text] [Related]
6. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells.
Ono M; Shimizu J; Miyachi Y; Sakaguchi S
J Immunol; 2006 Apr; 176(8):4748-56. PubMed ID: 16585568
[TBL] [Abstract][Full Text] [Related]
7. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
Yates J; Rovis F; Mitchell P; Afzali B; Tsang J; Garin M; Lechler RI; Lombardi G; Garden OA
Int Immunol; 2007 Jun; 19(6):785-99. PubMed ID: 17545278
[TBL] [Abstract][Full Text] [Related]
8. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.
Savage ND; de Boer T; Walburg KV; Joosten SA; van Meijgaarden K; Geluk A; Ottenhoff TH
J Immunol; 2008 Aug; 181(3):2220-6. PubMed ID: 18641362
[TBL] [Abstract][Full Text] [Related]
9. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
[TBL] [Abstract][Full Text] [Related]
10. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
11. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.
Allan SE; Crome SQ; Crellin NK; Passerini L; Steiner TS; Bacchetta R; Roncarolo MG; Levings MK
Int Immunol; 2007 Apr; 19(4):345-54. PubMed ID: 17329235
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Treg cells/T effector function by GITR signaling is context-dependent.
Ephrem A; Epstein AL; Stephens GL; Thornton AM; Glass D; Shevach EM
Eur J Immunol; 2013 Sep; 43(9):2421-9. PubMed ID: 23722868
[TBL] [Abstract][Full Text] [Related]
13. GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function.
Bushell A; Wood K
Am J Transplant; 2007 Apr; 7(4):759-68. PubMed ID: 17391121
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses.
de Boer OJ; van der Loos CM; Teeling P; van der Wal AC; Teunissen MB
J Histochem Cytochem; 2007 Sep; 55(9):891-8. PubMed ID: 17478450
[TBL] [Abstract][Full Text] [Related]
15. Expansion of regulatory GITR+CD25 low/-CD4+ T cells in systemic lupus erythematosus patients.
Nocentini G; Alunno A; Petrillo MG; Bistoni O; Bartoloni E; Caterbi S; Ronchetti S; Migliorati G; Riccardi C; Gerli R
Arthritis Res Ther; 2014 Sep; 16(5):444. PubMed ID: 25256257
[TBL] [Abstract][Full Text] [Related]
16. Role of antigen-specific regulatory CD4+CD25+ T cells in tolerance induction after neonatal IP administration of AAV-hF.IX.
Shi Y; Falahati R; Zhang J; Flebbe-Rehwaldt L; Gaensler KM
Gene Ther; 2013 Oct; 20(10):987-96. PubMed ID: 23759700
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells.
Lee SK; Choi BK; Kim YH; Kang WJ; Kim KH; Sakaguchi S; Suh JH; Kim TY; Kwon BS
Immunology; 2006 Dec; 119(4):479-87. PubMed ID: 17177830
[TBL] [Abstract][Full Text] [Related]
18. Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.
Cho JS; Hsu JV; Morrison SL
Cancer Immunol Immunother; 2009 Jul; 58(7):1057-69. PubMed ID: 19018533
[TBL] [Abstract][Full Text] [Related]
19. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.
Stephens GL; McHugh RS; Whitters MJ; Young DA; Luxenberg D; Carreno BM; Collins M; Shevach EM
J Immunol; 2004 Oct; 173(8):5008-20. PubMed ID: 15470044
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
